Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Glendale › NPI 1477610640
Hospital

Dignity Community Care

Dignity Community Care was paid $27.73M by Medicaid between Jan 2018 and Dec 2024, across 295 billing codes. Its largest line is 0450, Emergency room services — 30% of everything it billed.

33Billing provider infoDIGNITY COMMUNITY CARE
GLENDALE, CA 91204
33aNPI1477610640assigned 01/03/2007
28Total paid$27.73M
24GClaims708,516
24DCodes billed295
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in California

Rank by total paid#4 of 33
Median peer was paid$361K
This provider vs. median77×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018124,583$2.91M
201987,203$3.02M
202057,319$2.80M
202173,694$3.88M
2022108,791$5.77M
2023140,997$5.57M
2024incomplete115,929$3.78M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 30% 59,292 53,818 $8.23M
0250 6.3% 14,113 7,673 $1.75M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.3% 7,484 7,054 $1.19M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.5% 4,378 4,285 $963K
70450 Computed tomography, head or brain; without contrast material 2.7% 6,289 6,135 $744K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.1% 6,092 5,306 $582K
0272 2.0% 1,522 1,473 $554K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.9% 3,690 3,625 $540K
80053 Comprehensive metabolic panel 1.9% 27,383 25,193 $528K
71045 Radiologic examination, chest; single view 1.8% 17,195 16,568 $505K
A9150 Non-prescription drugs 1.5% 4,275 2,617 $429K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 1.5% 7,829 7,376 $423K
283 more codes
36415 Collection of venous blood by venipuncture 1.5% 21,501 $420K
99285 Emergency room visit (most serious) 1.5% 2,534 $405K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 13,400 $355K
0949 1.2% 10,623 $337K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.2% 3,509 $333K
0360 1.2% 3,248 $330K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.2% 21,072 $320K
0750 1.0% 1,201 $284K
71046 Radiologic examination, chest; 2 views <1% 5,028 $254K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,706 $248K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 4,344 $240K
J3490 Unclassified drugs <1% 16,091 $237K
0710 <1% 4,937 $217K
76801 <1% 2,543 $206K
Z7500 <1% 6,096 $204K
59025 Fetal non-stress test <1% 3,277 $179K
0301 <1% 1,442 $175K
96375 Therapeutic injection; each additional sequential IV push <1% 8,342 $174K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 31,949 $173K
Z7502 <1% 4,330 $163K
Z9725 <1% 3,715 $160K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 9,960 $158K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,411 $158K
81025 <1% 8,289 $158K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 3,514 $144K
82962 <1% 4,874 $143K
99199 Unlisted special service, procedure or report <1% 12,420 $122K
73564 <1% 1,316 $122K
72125 Computed tomography, cervical spine; without contrast material <1% 1,026 $119K
73610 <1% 1,460 $119K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,303 $117K
0762 <1% 963 $112K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,683 $112K
72100 <1% 1,178 $110K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,002 $99K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,248 $99K
76830 Ultrasound, transvaginal <1% 1,239 $99K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,393 $98K
11043 <1% 1,481 $98K
0760 <1% 11,987 $97K
84484 <1% 13,181 $90K
73030 <1% 1,370 $89K
0214 <1% 250 $88K
83880 <1% 7,310 $86K
A4217 Sterile water/saline, 500 ml <1% 794 $85K
93458 <1% 77 $84K
11044 <1% 309 $84K
81001 <1% 16,773 $78K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,646 $77K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,656 $73K
93971 <1% 927 $72K
96361 Intravenous infusion, hydration; each additional hour <1% 2,597 $70K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,892 $69K
73630 <1% 1,508 $68K
J2704 Injection, propofol, 10 mg <1% 3,331 $65K
0121 <1% 159 $65K
71275 Computed tomographic angiography, chest, with contrast material <1% 410 $64K
80048 Basic metabolic panel (calcium, ionized) <1% 5,218 $62K
73130 <1% 1,140 $61K
0510 <1% 10,110 $59K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,350 $58K
70496 <1% 302 $57K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,945 $56K
99221 <1% 2,730 $56K
46600 <1% 2,337 $54K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 675 $54K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 7,151 $53K
83690 <1% 10,758 $52K
J7030 Infusion, normal saline solution , 1000 cc <1% 10,036 $48K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,622 $47K
71250 <1% 430 $46K
72131 <1% 361 $46K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 356 $41K
93798 <1% 1,239 $41K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 749 $38K
85730 <1% 8,452 $36K
90715 <1% 1,599 $35K
Z6500 <1% 177 $34K
85610 <1% 10,110 $33K
73110 <1% 719 $33K
Z6410 <1% 2,483 $33K
0720 <1% 1,375 $32K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 389 $32K
70498 <1% 328 $29K
0270 <1% 10,850 $29K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,269 $28K
87040 <1% 1,661 $27K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 914 $26K
99153 Mod sedat endo service >5yrs <1% 550 $26K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,784 $24K
97162 <1% 712 $24K
J1644 Injection, heparin sodium, per 1000 units <1% 1,488 $23K
93970 <1% 226 $23K
73562 <1% 312 $22K
70486 <1% 207 $22K
0370 <1% 1,240 $21K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 467 $20K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,082 $20K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 440 $20K
J1815 Injection, insulin, per 5 units <1% 448 $17K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 711 $17K
72040 <1% 307 $17K
71101 <1% 84 $15K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 232 $15K
83605 <1% 2,709 $14K
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 9,973 $14K
86850 <1% 1,036 $14K
0761 <1% 906 $13K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,622 $13K
81003 <1% 3,437 $13K
0420 <1% 1,165 $13K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 136 $12K
97803 <1% 2,543 $12K
99401 <1% 2,599 $12K
0160 <1% 444 $11K
H1002 Prenatal care, at risk enhanced service; care coordination <1% 503 $11K
87186 <1% 631 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,477 $11K
A9270 Non-covered item or service <1% 3,540 $11K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 245 $10K
70551 Magnetic resonance imaging, brain; without contrast material <1% 54 $10K
83735 <1% 2,255 $10K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,034 $10K
Z6400 <1% 443 $10K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,606 $10K
36821 <1% 14 $10K
99152 <1% 470 $9K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 284 $9K
74018 <1% 232 $9K
87077 <1% 1,679 $9K
73140 <1% 255 $8K
84443 Thyroid stimulating hormone (TSH) <1% 934 $8K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 3,113 $8K
A4649 Surgical supply; miscellaneous <1% 441 $8K
93976 <1% 40 $8K
80076 <1% 519 $8K
84702 <1% 1,817 $7K
82805 <1% 214 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,635 $7K
73502 <1% 152 $7K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 164 $7K
76536 <1% 24 $6K
H1003 Prenatal care, at-risk enhanced service; education <1% 4,664 $6K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 45 $6K
H1001 Prenatal care, at-risk enhanced service; antepartum management <1% 912 $6K
86900 <1% 2,220 $6K
87430 <1% 615 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 192 $6K
Z1034 <1% 82 $6K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 197 $6K
0278 <1% 105 $6K
76376 <1% 174 $5K
G0378 Hospital observation service, per hour <1% 311 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,751 $5K
51741 <1% 436 $5K
86901 <1% 2,224 $5K
S3620 Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) <1% 30 $5K
73080 <1% 117 $5K
97116 <1% 1,692 $5K
87081 <1% 319 $4K
84703 <1% 998 $4K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 60 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 30 $4K
96376 <1% 436 $4K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 202 $4K
97802 <1% 297 $4K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,343 $4K
85379 <1% 693 $4K
J2060 Injection, lorazepam, 2 mg <1% 2,139 $4K
0514 <1% 1,030 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,887 $4K
80047 <1% 146 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,715 $3K
82553 <1% 350 $3K
96156 <1% 1,884 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,308 $3K
87428 <1% 18 $3K
85027 <1% 732 $3K
80061 Lipid panel <1% 605 $3K
76770 <1% 37 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,307 $3K
82550 <1% 603 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,675 $3K
99000 <1% 3,672 $3K
10060 <1% 62 $2K
87073 <1% 226 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 306 $2K
87070 <1% 227 $2K
72082 <1% 26 $2K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 376 $2K
88313 <1% 628 $2K
H2000 Comprehensive multidisciplinary evaluation <1% 517 $2K
12001 <1% 89 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 541 $2K
84145 <1% 313 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 666 $2K
73590 <1% 66 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 52 $2K
82150 <1% 318 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 79 $2K
29125 <1% 82 $1K
81002 <1% 843 $1K
0258 <1% 321 $1K
88304 <1% 126 $1K
87205 <1% 508 $1K
76870 <1% 28 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 352 $1K
Z6304 <1% 83 $1K
Z6204 <1% 83 $1K
Z6406 <1% 83 $1K
86140 <1% 291 $920.22
83874 <1% 314 $914.05
86308 <1% 51 $906.93
51702 <1% 56 $870.49
93017 <1% 40 $859.41
88312 <1% 571 $856.32
H1000 Prenatal care, at-risk assessment <1% 54 $793.22
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 13 $791.57
59425 <1% 163 $779.60
29130 <1% 16 $774.60
T5999 Supply, not otherwise specified <1% 171 $757.00
71010 <1% 48 $694.87
99386 <1% 44 $683.08
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 96 $630.52
97750 <1% 31 $615.20
C1769 Guide wire <1% 137 $608.75
80305 <1% 163 $587.69
74022 <1% 27 $585.91
Z7610 <1% 78 $535.20
76813 <1% 12 $531.95
85007 <1% 179 $471.78
84100 <1% 312 $469.44
87147 <1% 136 $457.87
51701 <1% 14 $438.85
S9452 Nutrition classes, non-physician provider, per session <1% 387 $404.52
96151 <1% 375 $363.79
E0562 Humidifier, heated, used with positive airway pressure device <1% 168 $346.86
73090 <1% 12 $346.84
87807 <1% 42 $336.13
83036 Hemoglobin; glycosylated (A1C) <1% 139 $332.42
84132 <1% 115 $317.61
99385 <1% 20 $236.54
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 69 $194.27
J3475 Injection, magnesium sulfate, per 500 mg <1% 41 $191.37
85384 <1% 13 $175.84
0430 <1% 287 $162.53
S0164 Injection, pantoprazole sodium, 40 mg <1% 61 $134.44
S0028 Injection, famotidine, 20 mg <1% 364 $134.34
0361 <1% 24 $124.50
85651 <1% 71 $115.83
0271 <1% 53 $84.00
96152 <1% 116 $77.33
0324 <1% 300 $69.75
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 140 $69.66
59430 <1% 18 $48.38
36600 <1% 13 $44.15
89055 <1% 12 $38.48
J1940 Injection, furosemide, up to 20 mg <1% 26 $35.80
J7060 5% dextrose/water (500 ml = 1 unit) <1% 40 $33.11
97035 <1% 27 $26.25
J1920 Injection, labetalol hydrochloride, 5 mg <1% 27 $22.89
85014 <1% 13 $16.40
85018 <1% 13 $16.19
99070 <1% 70 $13.95
0305 <1% 782 $10.96
0636 <1% 183 $7.09
0730 0% 477 $0.00
0300 0% 906 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 112 $0.00
0402 0% 37 $0.00
E0601 Continuous positive airway pressure (cpap) device 0% 93 $0.00
0302 0% 139 $0.00
0489 0% 70 $0.00
T4541 Incontinence product, disposable underpad, large, each 0% 272 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 13 $0.00
0320 0% 15 $0.00
0637 0% 19 $0.00
0307 0% 262 $0.00
0306 0% 575 $0.00
0352 0% 73 $0.00
T4535 Disposable liner/shield/guard/pad/undergarment, for incontinence, each 0% 190 $0.00
0310 0% 121 $0.00
88307 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGUOYAVATIN, KORA (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY COMMUNITY CARE